Target intelligence / Profile preview

Undecaprenyl pyrophosphate and undecaprenyl pyrophosphate phosphatase (UPP/UPP phosphatase)

Target
UPP/UPP phosphatase
Molecular classification
Enzyme, Lipid carrier, Hydrolase
01

Overview

Undecaprenyl pyrophosphate (UPP), also known as C55-isoprenyl pyrophosphate or bactoprenol pyrophosphate, is an essential lipid carrier in bacteria that transports peptidoglycan precursors across the cytoplasmic membrane (Manat et al., 2014, PubMed: 25100633). After delivering the precursor to the cell wall assembly site, UPP must be dephosphorylated by undecaprenyl pyrophosphate phosphatases, such as UppP (BacA), to regenerate undecaprenyl phosphate (UP) for further transport cycles (El Ghachi et al., 2004, PubMed: 15251211). This dephosphorylation step is a critical bottleneck in bacterial cell wall synthesis. The antibiotic bacitracin targets this process by forming a complex with UPP in the presence of divalent metal ions, which prevents the phosphatase from acting on the substrate (Stone and Strominger, 1971, PubMed: 4328831). This sequestration leads to the depletion of the available lipid carrier pool, effectively halting cell wall production and causing bacterial cell death. Because this lipid-mediated transport system is unique to prokaryotes, it serves as a specific target for antimicrobial therapy, although the systemic toxicity of bacitracin limits its clinical use to topical applications (StatPearls, 2023).

Other names
C55-isoprenyl pyrophosphateBactoprenol pyrophosphateUndecaprenyl-diphosphateUppPBacAUndecaprenyl pyrophosphate phosphatase
02

Mechanism of action

Bacitracin binds to undecaprenyl pyrophosphate in a metal-dependent manner, preventing its dephosphorylation by undecaprenyl pyrophosphate phosphatase and thereby blocking the recycling of the lipid carrier essential for cell wall synthesis.

03

Biological functions

Cell wall synthesisPeptidoglycan biosynthesisLipid recyclingTransmembrane transport
04

Disease associations

Bacterial infection
05

Safety considerations

Nephrotoxicity (systemic)Contact dermatitis (topical)
06

Interacting drugs

Bacitracin
07

Biomarkers

Minimum inhibitory concentration (MIC)Bacterial growth inhibition

Beyond the preview

Go deeper on Undecaprenyl pyrophosphate and undecaprenyl pyrophosphate phosphatase (UPP/UPP phosphatase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl pyrophosphate and undecaprenyl pyrophosphate phosphatase (UPP/UPP phosphatase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call